New prostate cancer treatment may eliminate recurrent tumorsPatricia Anstett
According to Dr. Raman, "This image-guided therapy maximizes our ability to killcancer cellswhile minimizingcollateral damageto the prostate to achieve the ultimate trifecta inprostate cancer treatment: full local cancer control while maintaining urinary continence and potency. The latter are the complic...
CHICAGO, June 4 (Xinhua) -- A combination of two existing prostate cancer therapies could extend lives of men with advanced, high-risk prostate cancer, a study showed. The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed,...
While the FDA recently approved this form of treatment, which has been called a lumpectomy for men, for tissue ablation, HIFU has failed to gain approval as a treatment for prostate cancer. As a result, insurers won't cover HIFU, costing men who are treated with it approximately $25,000 ...
12 RSNA2022:胸部恶性肿瘤-非小细胞肺癌的影像与治疗Thoracic Malignancy I Imaging and Treatment in NSCLC 1:02:12 RSNA2022:人工智能的儿科影像学的应用(Artificial Intelligence in Pediatric Radiology) 1:00:51 RSNA2022:结直肠影像学(Colorectal Imaging) 1:00:51 RSNA2022:头部及面部创伤(Head and Face ...
In recent years the pace of research in prostate cancer has increased dramatically. Creative ideas in combination with new and emerging technologies have led to an explosion of discovery. These types of advances in prostate cancer research presage an era of new treatment strategies based on an unde...
Welcome to Prostate Cancer 911, your trusted center for comprehensive prostate cancer surgery and treatment in New York.
000 die from prostate cancer (GLOBOCAN). There was over four times the incidence of prostate cancer in 2017 as in the 1950s, but at the same time, the treatments have been improving, so many more live longer, and die with, rather than of, prostate cancer. Nevertheless, more effective ...
eradicating that tumourcell population, there is a risk of subsequent uncontrolled growth of the tumour. The cancer stem cells are often unresponsive to both hormonal treatment and to chemotherapy, so it is essential to develop a direct treatment towards all types of cancer cells", says Anders B...
May 31st 2022 Podcast Judd W. Moul, MD, spoke with CancerNetwork® about the latest research from the journal ONCOLOGY® on the treatment of a patients with evidence of prostate cancer despite multiple negative prognostic tests. SBRT Emerges as Viable Treatment for Localized Prostate Cancer Tim...